Wellington Partners

Wellington Partners is a leading European venture capital firm focusing on early- and growth-stage life science companies from Germany, Europe and beyond, with breakthrough and truly innovative technologies. The firm invests in cutting-edge life science companies in the fields of biotechnology, therapeutics, medical devices, diagnostics and digital health. Wellington Partners provides world class entrepreneurs with capital for the financing of breakthrough products with the potential to decisively improve current standard of care and, most importantly, the lives of patients. The firm proactively sources deals and leads or co-leads financing rounds, from early stage to expansion stage and selected PIPE investments. Ticket sizes typically range from EUR 2 million to EUR 20 million. With a highly experienced team combining MDs and PhDs, the firm offers board level strategic support while entrepreneurs exercise operational control, helping to accelerate preclinical and clinical development, regulatory approval processes, and drive successful market entry into the most important healthcare markets in Europe, the U.S. and Asia.